Chemoinformaics analysis of Apigenin 5-O-beta-D-glucopyranoside
| Molecular Weight | 432.381 | nRot | 4 |
| Heavy Atom Molecular Weight | 412.221 | nRig | 24 |
| Exact Molecular Weight | 432.106 | nRing | 4 |
| Solubility: LogS | -3.916 | nHRing | 2 |
| Solubility: LogP | 0.982 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
| nHA | 10 | APOL | 56.4259 |
| nHD | 6 | BPOL | 26.1401 |
| QED | 0.331 |
| Synth | 3.839 |
| Natural Product Likeliness | 2.008 |
| NR-PPAR-gamma | 0.288 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.972 |
| HIA | 0.491 |
| CACO-2 | -6.153 |
| MDCK | 0.0000136 |
| BBB | 0.036 |
| PPB | 0.891001 |
| VDSS | 0.89 |
| FU | 0.137155 |
| CYP1A2-inh | 0.292 |
| CYP1A2-sub | 0.055 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.024 |
| CYP2c9-sub | 0.697 |
| CYP2d6-inh | 0.156 |
| CYP2d6-sub | 0.278 |
| CYP3a4-inh | 0.078 |
| CYP3a4-sub | 0.03 |
| CL | 4.041 |
| T12 | 0.769 |
| hERG | 0.291 |
| Ames | 0.622 |
| ROA | 0.026 |
| SkinSen | 0.638 |
| Carcinogencity | 0.25 |
| EI | 0.133 |
| Respiratory | 0.033 |
| NR-Aromatase | 0.89 |
| Antiviral | Yes |
| Prediction | 0.865735 |